Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation

NCT07003737 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia, B-precursor

Interventions

DRUG: Blinatumomab
OTHER: Consolidation Chemotherapy or Direct Allogeneic HSCT

Sponsor

First Affiliated Hospital of Zhejiang University